A NEW FAMILIAL VARIANT OF ANTITHROMBIN. III: ANTITHROMBINE III PARIS'WOLF M; BOYER C; LAVERGNE JM et al.1982; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1982; VOL. 51; NO 2; PP. 285-295; BIBL. 35 REF.Article

ANTITHROMBIN III (AT III) PADUA₂: A "NEW" CONGENITAL ABNORMALITY WITH DEFECTIVE HEPARIN CO-FACTOR ACTIVITIES BUT NO THROMBOTIC DISEASEGIROLAMI A; FABRIS F; CAPPELLATO G et al.1983; BLUT; ISSN 0006-5242; DEU; DA. 1983; VOL. 47; NO 2; PP. 93-103; BIBL. 31 REF.Article

L'antithrombine III = Antithrombin IIIMASSIGNON, D.Lyon pharmaceutique. 1985, Vol 36, Num 1, pp 5-11, issn 0024-7804Article

Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionPERRY, D. J; HARPER, P. L; FAIRHAM, S et al.FEBS letters. 1989, Vol 254, Num 1-2, pp 174-176, issn 0014-5793, 3 p.Article

Dysfunctional antithrombin III in sick premature infantsANDREW, M; MASSICOTTE-NOLAN, P; MITCHELL, L et al.Pediatric research. 1985, Vol 19, Num 2, pp 237-239, issn 0031-3998Article

DEFICITS CONSTITUTIONNELS ET ACQUIS EN ANTITHROMBINE III: A PROPOS DE DEUX OBSERVATIONSLAHARRAGUE P; CAUSSE B; BOUISSOU F et al.1980; REV. MED. TOULOUSE; FRA; DA. 1980; VOL. 16; NO 4; PP. 201-205; (4 P.); ABS. ENG; BIBL. 16 REF.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

Antithrombin III and arterial diseaseCORTELLARO, M.Lancet (British edition). 1991, Num 8781, pp 1525-1526, issn 0140-6736Article

Isolation and characterization of a hereditary abnormal untithrombin III Antithrombin III ToyamäKOIDE, T; TAKAHASHI, K; ODANI, S et al.Thrombosis research. 1983, Vol 31, Num 2, pp 319-328, issn 0049-3848Article

Studies of the heterogeneity of antithrombin III concentratesBARROWCLIFFE, T. W; EGGLETON, C. A; MAHMOUD, M et al.British journal of haematology. 1983, Vol 55, Num 1, pp 37-46, issn 0007-1048Article

The impact of total parenteral nutrition on antithrombin IIINEHME, A. E; BOYD, M. C.JPEN. Journal of parenteral and enteral nutrition. 1983, Vol 7, Num 6, pp 573-574, issn 0148-6071Article

GESAMTES UND AKTIVIERTES ANTITHROMBIN III: WIRKUNG UND NACHWEIS = ANTITHROMBINE III TOTALE ET ACTIVEE: EFFET ET MISE EN EVIDENCEROKA L; BLEYL H.1979; Z. MED. LAB.-DIAGNOST.; DDR; DA. 1979; VOL. 20; NO 2; PP. 68-77; ABS. RUS/ENG; BIBL. 3 REF.Article

Functional determination of antithrombin III in clinical samples and therapeutic concentratesJAWED FAREED; WALENGA, J. M; SVENDSEN, L. G et al.Seminars in thrombosis and hemostasis. 1986, Vol 12, Num 4, pp 328-334, issn 0094-6176Article

Thrombin generation and inactivation in the presence of antithrombin III and heparinLINDHOUT, T; BARUCH, D; SCHOEN, P et al.Biochemistry (Easton). 1986, Vol 25, Num 20, pp 5962-5969, issn 0006-2960Article

High and low affinity heparin compared with unfractionated heparin as antithrombotic drugsMERTON, R. E; THOMAS, D. P; HAVERCROFT, S. J et al.Thrombosis and haemostasis. 1984, Vol 51, Num 2, pp 254-256, issn 0340-6245Article

Coagulation, fibrinolytic and antithrombin III profiles monitored in severely infected patientsSTENBJERG, S; PEDERSEN, E. B; LAURSEN, H et al.Thrombosis research. 1983, Vol 31, Num 4, pp 635-640, issn 0049-3848Article

CLINICAL LABORATORY DETERMINATION OF ANTITHROMBINE III: A NEW SEMI-AUTOMATED METHODBRANDT JT; SENHAUSER DA.1980; AMER. J. CLIN. PATHOL.; USA; DA. 1980; VOL. 73; NO 5; PP. 687-691; BIBL. 18 REF.Article

L'ANTITHROMBINE III DANS LES ETATS EXPERIMENTAUX ET PATHOLOGIQUES S'ACCOMPAGNANT D'UNE SYNTHESE ACCRUE DE THROMBINEPASTOROVA VE.1980; VEST. MOSKOV. UNIV., 16; SUN; DA. 1980; NO 1; PP. 18-24; ABS. ENG; BIBL. 1 P.Article

AN IMPROVED CLINICAL ASSAY FOR ANTITHROMBIN III (HEPARIN COFACTOR)CHOCKLEY M; DENNER JA.1980; ANN. J. CLIN. PATHOL.; ISSN 0002-9173; USA; DA. 1980; VOL. 74; NO 2; PP. 213-217; BIBL. 6 REF.Article

EVALUATION OF AN AMIDOLYTIC HEPARIN ASSAY METHOD: INCREASED SENSITIVITY BY ADDING PURIFIED ANTITHROMBIN III.TEIEN AN; LIE M.1977; THROMBOSIS RES.; G.B.; DA. 1977; VOL. 10; NO 3; PP. 399-410; BIBL. 15 REF.Article

Manufacturing process for antithrombin III concentrate: Viral validation studies and effects of column re-use on viral safetyFALBO, A.Developments in biologicals. 2003, Vol 113, pp 81-88, issn 1424-6074, 8 p.Conference Paper

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinLANE, D. A; FLYNN, A; IRELAND, H et al.British journal of haematology. 1987, Vol 65, Num 4, pp 451-456, issn 0007-1048Article

A pasteurized antithrombin III concentrate for clinical useSMITH, J. K; WINKELMAN, L; EVANS, D. R et al.Vox sanguinis (Basel. 1956). 1985, Vol 48, Num 6, pp 325-332, issn 0042-9007Article

Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of α-thrombinOLSON, S. T.The Journal of biological chemistry (Print). 1985, Vol 260, Num 18, pp 10153-10160, issn 0021-9258Article

In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic poolsCARLSON, T. H; SIMON, T. L; ATENCIO, A. C et al.Blood. 1985, Vol 66, Num 1, pp 13-19, issn 0006-4971Article